Skip to main content
Article
Interleukin 2 and lymphokine-activated killer cell therapy : analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen
Cancer Research (1990)
  • Jeffrey W. Clark, National Institutes of Health
  • John W. Smith, National Institutes of Health
  • Ronald G. Steis, National Institutes of Health
  • Walter J. Urba, National Institutes of Health
  • Edward Crum, National Institutes of Health
  • Robin Miller, National Institutes of Health
  • John McKnight, National Institutes of Health
  • JoAnn Beman, National Institutes of Health
  • Henry C. Stevenson, National Institutes of Health
  • Stephen Creekmore, National Institutes of Health
  • Michael Stewart, National Institutes of Health
  • Kevin Conlon, National Institutes of Health
  • Mario Sznol, National Institutes of Health
  • Peter Kremers, Memorial Hospital of South Bend
  • Paul Cohen, National Institutes of Health
  • Dan L. Longo, National Institutes of Health
Publication Date
November 15, 1990
Citation Information
Jeffrey W. Clark, John W. Smith, Ronald G. Steis, Walter J. Urba, et al.. "Interleukin 2 and lymphokine-activated killer cell therapy : analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen" Cancer Research Vol. 50 Iss. 22 (1990) p. 7343 - 7350
Available at: http://works.bepress.com/walter-urba/66/